Internal Medicine, Rheumatology · Los Angeles, CA
NPI
1003172529
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 UCLA Medical Plz Ste 365b
Los Angeles, CA, 90095
Phone (310) 825-2448
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
223 services
Medicare patients, 2024
60
Average age 68
Drug cost, 2024
$1.6M
411 prescriptions
Company payments, 2025
$98.03
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sangmee Bae was code 99215 (office e&m - established), 61 times for 26 patients. In total Sangmee Bae billed 223 services in 17 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 61 | 26 | $113.04 | $6,896 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 20 | $13.70 | $507 |
| 99233 Hospital E&M - Subsequent | Facility | 27 | 12 | $98.08 | $2,648 |
| 99214 Office E&M - Established | Facility | 16 | 14 | $56.59 | $905 |
By year: 2022 $16K for 184 services; 2023 $19K for 228 services; 2024 $18K for 223 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sangmee Bae prescribed most often to Medicare patients was Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50), with 95 prescriptions and refills. In total Sangmee Bae wrote 411 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 95 | 95 | Under 11 | $834K |
| Prednisone Generic | 77 | 103 | 13 | $360 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 26 | 26 | Under 11 | $213K |
| Mycophenolic Acid Mycophenolate Sodium | 20 | 22 | Under 11 | $8,156 |
| Methotrexate Methotrexate Sodium | 20 | 43 | Under 11 | $331 |
| Hydroxychloroquine Sulfate Generic | 15 | 27 | Under 11 | $496 |
| Diclofenac Sodium Generic | 15 | 15 | Under 11 | $680 |
| Meloxicam Generic | 12 | 24 | Under 11 | $60.05 |
| Tavneos Avacopan | 11 | 11 | Under 11 | $159K |
| Ketoconazole Generic | 11 | 11 | Under 11 | $101 |
| Orencia Clickject Abatacept | 11 | 11 | Under 11 | $59K |
| Mycophenolate Mofetil Generic | 11 | 23 | Under 11 | $1,356 |
Brand drugs: 167 claims; generic drugs: 244 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sangmee Bae $98.03 ($98.03 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $98.03.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $98.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.